背景:宫腔镜检查是诊断和治疗宫内病变的金标准。微型切除镜的出现预示着宫内手术的新时代,在住院和门诊设置。
目的:为了评估有效性,安全,微型切除镜治疗宫内病变的可行性。
方法:在电子数据库中搜索英语试验,这些试验描述了直到2023年4月30日用微型电切镜进行的子宫病理学手术。
方法:报告微型电切镜治疗子宫病变的回顾性或前瞻性原始研究被认为符合纳入标准。
方法:有关研究特征的数据,包括群体的特征,外科手术,并发症,并收集结果/结果。
结果:本系统综述纳入了7篇符合纳入标准的论文。由于数据异质性,无法进行定量分析。结果的描述性综合提供了相应的病理宫腔镜切除/矫正:息肉和肌瘤,子宫隔膜,宫内粘连,和峡部。
结论:微型电切镜有望在许多病理的宫腔镜手术中发挥主导作用,在住院和门诊设置。由于小型切除镜的某些应用尚未得到彻底调查,未来的研究应该解决当前的知识差距,在特定应用中设计高质量的比较试验。
BACKGROUND: Hysteroscopy represents the gold standard for the diagnosis and treatment of intrauterine pathologies. The advent of the mini-resectoscope heralded a new era in intrauterine surgery, both in inpatient and outpatient settings.
OBJECTIVE: To evaluate the effectiveness, safety, and feasibility of the mini-resectoscope for the treatment of intrauterine pathologies.
METHODS: Electronic databases were searched for English-language trials describing surgical procedures for uterine pathologies performed with a mini-resectoscope until 30 April 2023.
METHODS: Retrospective or prospective original studies reporting the treatment of uterine pathologies with mini-resectoscope were deemed eligible for the inclusion.
METHODS: Data about study features, characteristics of included populations, surgical procedures, complications, and results/outcomes were collected.
RESULTS: Seven papers that met the inclusion criteria were included in this systematic review. Quantitative analysis was not possible due to data heterogeneity. A descriptive synthesis of the results was provided accordingly to the pathology hysteroscopically removed/corrected: polyps and myomas, uterine septum, intrauterine synechiae, and isthmocele.
CONCLUSIONS: The mini-resectoscope is poised to play a leading role in hysteroscopic surgery for many pathologies, both in inpatient and outpatient settings. Since some applications of the mini-resectoscope have not yet been thoroughly investigated, future studies should address current knowledge gaps, designing high-quality comparative trials on specific applications.